An H-2Kb/OVA hybridoma cell line producing a monoclonal antibody specific for the H-2Kb/SIINFEKL complex (clone 25-D1.16) as described in Immunity 1997 Jun;6(6):715-26 and developed in the laboratory of Dr. Ronald Germain at the National Institute of Allergy and Infectious Diseases.
Commercial Applications
- A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
- Speed up product development with NIH developed material that has already been tested and validated.